Yüklüyor......
Recombinant human factor VIIa (rFVIIa) in hemophilia: mode of action and evidence to date
Recombinant activated factor VII (rFVIIa) is a bypassing agent widely used both in the treatment and prevention of hemorrhagic complications due to hemophilia with inhibitor. In such cases, antihemophilic factors cannot be used. The normal physiology of factor VII/ factor VIIa (FVII/FVIIa) in the he...
Kaydedildi:
| Yayımlandı: | Ther Adv Hematol |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
SAGE Publications
2017
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5703115/ https://ncbi.nlm.nih.gov/pubmed/29204261 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2040620717737701 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|